CRISPR Therapeutics Names A.J. Silver CFO, Succeeding Raju Prasad

Bitget2026/10/19 20:11

By:Bitget

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

CRISPR Therapeutics appointed its senior vice president of finance as chief financial officer, effective today.
Outgoing CFO Raju Prasad is leaving to pursue external opportunities.
The successor joined in October 2018 and had served as senior vice president of finance since January 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610191605PRIMZONEFULLFEED9848665) on October 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

CRISPR Therapeutics Names A.J. Silver CFO, Succeeding Raju Prasad

You may also like

Crypto prices